SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-076327
Filing Date
2015-11-05
Accepted
2015-11-05 17:23:31
Documents
3
Period of Report
2015-10-30
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-22446_18k.htm 8-K 27044
2 EX-99.1 a15-22446_1ex99d1.htm EX-99.1 84696
3 GRAPHIC g224461mm01i001.jpg GRAPHIC 4472
  Complete submission text file 0001104659-15-076327.txt   119213
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 151201750
SIC: 2834 Pharmaceutical Preparations